Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Balsa

Showing results (211-220 of 246) with videos related to

Pageof 25
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|October 3, 2018
Specific Association of HLA-DRB1*03 With Anti-Carbamylated Protein Antibodies in Patients With Rheumatoid ArthritisCristina Regueiro, Luis Rodriguez-Rodriguez, Ana Triguero-Martinez, et al.
JMIR Human Factors|April 23, 2025
Digital Health Intervention for Patient Monitoring in Immune-Mediated Inflammatory Diseases: Cocreation and Feasibility Study of the IMIDoc PlatformDiego Benavent, Jose M Iniesta-Chamorro, Marta Novella-Navarro, et al.
Annals of the Rheumatic Diseases|December 17, 2013
Genetic risk scores and number of autoantibodies in patients with rheumatoid arthritisMarthe T Maehlen, Inge C Olsen, Bettina K Andreassen, et al.
Arthritis and Rheumatism|August 29, 2009
Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factorsMarian Suarez-Gestal, Manuel Calaza, Rebeca Dieguez-Gonzalez, et al.
Frontiers in Immunology|February 29, 2024
Exploring candidate biomarkers for rheumatoid arthritis through cardiovascular and cardiometabolic serum proteome profilingLaura Cuesta-López, Alejandro Escudero-Contreras, Yas Hanaee, et al.
Annals of the Rheumatic Diseases|October 8, 2013
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)Maxime Dougados, Martin Soubrier, Anna Antunez, et al.
Reumatologia Clinica|November 26, 2023
Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritisAlejandro Balsa, Petra Díaz Del Campo Fontecha, Lucía Silva Fernández, et al.
Scientific Reports|May 31, 2018
Association of a rare variant of the TNFSF13B gene with susceptibility to Rheumatoid Arthritis and Systemic Lupus ErythematosusDavid González-Serna, Lourdes Ortiz-Fernández, Sofía Vargas, et al.
RMD Open|February 23, 2024
Exploring the influence of baseline rheumatoid factor levels on TNF inhibitor retention rate in patients with rheumatoid arthritis: a multicentre and retrospective studyClementina López-Medina, Jerusalem Calvo-Gutiérrez, M Carmen Ábalos-Aguilera, et al.
Clinical and Experimental Rheumatology|October 2, 2019
"There is something you must see": breaking down the remission concept in rheumatoid arthritis from a rheumatologist's perspectiveCarlos Acebes, Jose Luis Andreu, Alejandro Balsa, et al.
Pageof 25

Showing results (211-220 of 246) with videos related to

Sort By:
Pageof 25
Arthritis & Rheumatology (Hoboken, N.J.)|October 3, 2018
Specific Association of HLA-DRB1*03 With Anti-Carbamylated Protein Antibodies in Patients With Rheumatoid ArthritisCristina Regueiro, Luis Rodriguez-Rodriguez, Ana Triguero-Martinez, et al.
JMIR Human Factors|April 23, 2025
Digital Health Intervention for Patient Monitoring in Immune-Mediated Inflammatory Diseases: Cocreation and Feasibility Study of the IMIDoc PlatformDiego Benavent, Jose M Iniesta-Chamorro, Marta Novella-Navarro, et al.
Annals of the Rheumatic Diseases|December 17, 2013
Genetic risk scores and number of autoantibodies in patients with rheumatoid arthritisMarthe T Maehlen, Inge C Olsen, Bettina K Andreassen, et al.
Arthritis and Rheumatism|August 29, 2009
Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factorsMarian Suarez-Gestal, Manuel Calaza, Rebeca Dieguez-Gonzalez, et al.
Frontiers in Immunology|February 29, 2024
Exploring candidate biomarkers for rheumatoid arthritis through cardiovascular and cardiometabolic serum proteome profilingLaura Cuesta-López, Alejandro Escudero-Contreras, Yas Hanaee, et al.
Annals of the Rheumatic Diseases|October 8, 2013
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)Maxime Dougados, Martin Soubrier, Anna Antunez, et al.
Reumatologia Clinica|November 26, 2023
Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritisAlejandro Balsa, Petra Díaz Del Campo Fontecha, Lucía Silva Fernández, et al.
Scientific Reports|May 31, 2018
Association of a rare variant of the TNFSF13B gene with susceptibility to Rheumatoid Arthritis and Systemic Lupus ErythematosusDavid González-Serna, Lourdes Ortiz-Fernández, Sofía Vargas, et al.
RMD Open|February 23, 2024
Exploring the influence of baseline rheumatoid factor levels on TNF inhibitor retention rate in patients with rheumatoid arthritis: a multicentre and retrospective studyClementina López-Medina, Jerusalem Calvo-Gutiérrez, M Carmen Ábalos-Aguilera, et al.
Clinical and Experimental Rheumatology|October 2, 2019
"There is something you must see": breaking down the remission concept in rheumatoid arthritis from a rheumatologist's perspectiveCarlos Acebes, Jose Luis Andreu, Alejandro Balsa, et al.
Pageof 25